REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $79,093,329 | +165.8% | 775,729 | +137.0% | 0.02% | +128.6% |
| Q1 2023 | $29,758,753 | +83.6% | 327,307 | -23.3% | 0.01% | +75.0% |
| Q4 2022 | $16,204,103 | +41.4% | 426,536 | -6.4% | 0.00% | +33.3% |
| Q3 2022 | $11,456,000 | +0.4% | 455,915 | +21.5% | 0.00% | 0.0% |
| Q2 2022 | $11,406,000 | -27.9% | 375,303 | -22.3% | 0.00% | 0.0% |
| Q1 2022 | $15,830,000 | +71.6% | 483,243 | +38.2% | 0.00% | +200.0% |
| Q4 2021 | $9,223,000 | -44.7% | 349,721 | +110.8% | 0.00% | -75.0% |
| Q3 2021 | $16,691,000 | +10.0% | 165,893 | +54.8% | 0.00% | 0.0% |
| Q2 2021 | $15,172,000 | +31.3% | 107,200 | -7.5% | 0.00% | 0.0% |
| Q1 2021 | $11,557,000 | -1.9% | 115,929 | +21.6% | 0.00% | +33.3% |
| Q4 2020 | $11,782,000 | -9.0% | 95,303 | -28.3% | 0.00% | 0.0% |
| Q3 2020 | $12,944,000 | -28.0% | 132,872 | +15.4% | 0.00% | -50.0% |
| Q2 2020 | $17,970,000 | -53.0% | 115,180 | -56.6% | 0.01% | -64.7% |
| Q1 2020 | $38,267,000 | -2.7% | 265,121 | +37.7% | 0.02% | 0.0% |
| Q4 2019 | $39,347,000 | +674.5% | 192,470 | +204.2% | 0.02% | +750.0% |
| Q3 2019 | $5,080,000 | -28.2% | 63,272 | -15.6% | 0.00% | -33.3% |
| Q2 2019 | $7,073,000 | +33.7% | 74,969 | +21.1% | 0.00% | 0.0% |
| Q1 2019 | $5,291,000 | +203.9% | 61,897 | +99.5% | 0.00% | +200.0% |
| Q4 2018 | $1,741,000 | -68.9% | 31,030 | -54.7% | 0.00% | -66.7% |
| Q3 2018 | $5,596,000 | +1829.7% | 68,462 | +726.6% | 0.00% | – |
| Q2 2018 | $290,000 | -41.6% | 8,282 | -65.9% | 0.00% | – |
| Q1 2018 | $497,000 | +94.1% | 24,252 | +194.6% | 0.00% | – |
| Q3 2017 | $256,000 | – | 8,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |